Human Intestinal Peptides Evaluation and Research (HIPER)
Effects of Different Metabolic States and Surgical Models on Glucose Metabolism and Secretion of Ileal L-cell Peptides
Sponsor: Turkish Metabolic Surgery Foundation
A observational or N/A phase clinical study on Diabetes Mellitus, Type 2 and Obesity, this trial is ongoing. The trial is conducted by Turkish Metabolic Surgery Foundation and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Aug 2018 — Nov 2020 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Enrolling By Invitation
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — May 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Aug 2017 [monthly]
Enrolling By Invitation NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Turkish Metabolic Surgery Foundation
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.